(RTTNews) - Merck & Co Inc. (MRK) announced that KEYTRUDA (pembrolizumab) plus Trodelvy (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% compared to KEYTRUDA plus c ...

Here are all the highlights of Winterthur's biggest offering of the year, one of Delaware's most anticipated seasonal events. Point-to-Point at Winterthur is best known for its heart-pounding ...

Merck KGaA’s antibody-drug conjugate (ADC), precemtabart tocentecan, has shown to be safe and tolerable in a Phase Ib trial.

[Savings concept - Piggy bank on US nickel coins] PM Images This week's dividend activity included increased payouts from BMO Financial (BMO [https://seekingalpha.com/symbol/BMO]) and Royal Bank of Ca ...

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...

In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on ...

Merck KGaA (Merck) is filing for global regulatory approvals of its CSF-1R inhibitor pimicotinib after it met the primary and ...

Germany’s Merck KGaA (MRK: DE) today announced the presentation of detailed positive results from Part 1 of the global Phase ...

The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...